Patents by Inventor Ulrich F. Tillman

Ulrich F. Tillman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Patent number: 7914795
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: March 29, 2011
    Assignee: Emergent Product Development Gaithersburg, Inc.
    Inventors: Kenneth Tucker, Laura Plosila, Ulrich F. Tillman
  • protein, nucleic acid sequence and uses thereof
    Patent number: 7846451
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein polypeptide and polypeptides derived therefrom (collectively “OMP21”), nucleotide sequences encoding said OMP21, and antibodies that specifically bind OMP21. Also disclosed are pharmaceutical compositions including prophylactic or therapeutic compositions, which may be immunogenic compositions including vaccines, comprising OMP21, antibodies thereto or nucleotides encoding same. The invention additionally discloses methods of inducing an immune response to M. catarrhalis and OMP21 in an animal, preferably a human, methods of treating and methods of diagnosing Moraxella infections in an animal, preferably a human, and kits therefor.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: December 7, 2010
    Assignee: Emergent Product Development Gaithersburg, Inc.
    Inventors: Kenneth Tucker, Ulrich F. Tillman
  • MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
    Publication number: 20100021492
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP 106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP 106 polypeptides and OMP 106-derived polypeptides in animals.
    Type: Application
    Filed: August 14, 2009
    Publication date: January 28, 2010
    Inventors: Kenneth TUCKER, Laura PLOSILA, Ulrich F. TILLMAN
  • outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Patent number: 7576179
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: August 18, 2009
    Assignee: Emergent Product Development of Gaithersburg, Inc.
    Inventors: Kenneth Tucker, Laura Plosila, Ulrich F. Tillman
  • Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Patent number: 6214981
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: April 10, 2001
    Assignee: Antex Biologics Inc.
    Inventors: Kenneth Tucker, Laura Plosila, Ulrich F. Tillman